Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004485614 | SCV004979729 | uncertain significance | Inborn genetic diseases | 2023-11-18 | criteria provided, single submitter | clinical testing | The c.577C>T (p.P193S) alteration is located in exon 3 (coding exon 3) of the XPNPEP3 gene. This alteration results from a C to T substitution at nucleotide position 577, causing the proline (P) at amino acid position 193 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Neuberg Centre For Genomic Medicine, |
RCV004771550 | SCV005382487 | uncertain significance | Nephronophthisis-like nephropathy 1 | 2023-05-20 | criteria provided, single submitter | clinical testing | The observed missense variant c.577C>T(p.Pro193Ser) in XPNPEP3 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.577C>T variant has 0.001% allele frequency in gnomAD Exomes. The amino acid Proline at position 193 is changed to a Serine changing protein sequence and it might alter its composition and physico-chemical properties. Multiple lines of computational evidence (Polyphen, SIFT and Mutation Taster) predict no damaging effect on protein structure and function for this variant.The reference amino acid change in XPNPEP3 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. |